Work

A Randomized, Double-blind, Placebo-controlled Trial Evaluating the Safety, Tolerability, and Pharmacodynamics of Saracatinib in Idiopathic Pulmonary Fibrosis

Year: 2025

Type: article

Source: CHEST Journal

DOI: 10.1016/j.chest.2025.09.097

Authors: GREGORY P DOWNEY, NAFTALI KAMINSKI, JEFFREY J SWIGRIS, MARIA PADILLA, DANIELLE E ANTIN-OZERKIS, SUSAN K MATHAI, MICHAEL P MOHNING, SAMANTHA RAYMOND, DITIAN LI, EMILIA BAGIELLA, STEPHEN HUMPHRIES, DAVID LYNCH, FARIDA AHANGARI, AYAD ABDUL-AHAD, VIJAY ZALA, IMRE NOTH, JOHN KIM, ANNETINE GELIJNS

Language: English

Topic: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4416701047

FWCI:

Cites:

Cited by:

Related to: